Description
Pulmofirst 62.5mg Tablets contain Bosentan, an endothelin receptor antagonist used to treat pulmonary arterial hypertension (PAH). This medication helps to lower blood pressure in the lungs, improving the heart’s ability to pump blood efficiently. Pulmofirst 62.5mg Tablets are prescribed to improve exercise capacity and slow the progression of PAH, enhancing the quality of life for patients with this condition.
Dosage/Directions: Take Pulmofirst 62.5mg Tablets exactly as prescribed by your doctor. The usual starting dose is 62.5 mg taken twice daily for the first 4 weeks, followed by an increase to 125 mg twice daily if tolerated. It is important to take the medication at the same times each day, with or without food. Do not alter the dosage without consulting your healthcare provider.
Side Effects: Common side effects include headache, flushing, low blood pressure, and nasal congestion. Serious side effects may include liver problems, anemia, and fluid retention. Regular monitoring of liver function and blood counts is necessary. Contact your doctor immediately if you experience symptoms such as jaundice, severe fatigue, or unusual swelling.
